Skip to main content
Clinical Trials/CTRI/2024/02/062231
CTRI/2024/02/062231
Recruiting
Phase 4

A prospective, single arm, post market clinical follow-up of Extension Line & Needle Free Connector to explore safety and performance in Adult & Paediatric subjects in Indian Population. - NI

Romsons Group Private Limited0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: O- Medical and Surgical
Sponsor
Romsons Group Private Limited
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Pms

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1 Males and Females Adults \& Paediatrics who are expected to require Exteena IV extension line with needle free connector \& Safsite IV needle free connector for attachment to IV line
  • 2 Subject who can provide Informed Consent Form Adult in writing and medically in a position to undergo consent and screening process OR in case of Paediatrics parent of child LAR Legally Acceptable Representative can provide Informed Assent Form Child
  • 3 The subject who is willing and able to comply with the requirement of the follow\-up OR in case of Paediatrics parent of child LAR Legally Acceptable Representative who is willing and able to comply with the requirement of the follow\-up

Exclusion Criteria

  • 1 Subject present with medical emergency where treatment is more priority than the informed consent informed assent process
  • 2 Subject having bleeding disorders condition where high pressure power injectors are used etc
  • 3 Subject who cannot provide Informed Consent Form Adult such as unconscious mentally challenged subject OR in case of Paediatrics parent of child LAR Legally Acceptable Representative who cannot provide Informed Assent Form Child or give permission etc
  • 4 Any known allergy with any of the material of Exteena IV extension line with needle free connector \& Safsite IV needle free connector and its components
  • 5 Other conditions which in the opinion of investigators make the subject unsuitable for enrolment or could interfere with his her participation in and completion of the clinical investigation plan
  • 6 Subject who is pregnant or breast feeding
  • 7 Subject is of childbearing potential and has a positive pregnancy test since admission to the hospital
  • 8 Participation in another research study involving an active investigation within 30 days prior to consent

Outcomes

Primary Outcomes

Not specified

Similar Trials